Andrew Combs is Chief Chemistry Officer of Prelude Therapeutics Inc. Currently has a direct ownership of 377,623 shares of PRLD, which is worth approximately $366,294. The most recent transaction as insider was on Dec 23, 2024, when has been sold 60,000 shares (Common Stock) at a price of $1.37 per share, resulting in proceeds of $82,200. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 378K
24.04% 3M change
24.04% 12M change
Total Value Held $366,294

Andrew Combs Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 23 2024
BUY
Open market or private purchase
$82,200 $1.37 p/Share
60,000 Added 13.71%
377,623 Common Stock
Dec 20 2024
BUY
Open market or private purchase
$3,536 $1.15 p/Share
3,075 Added 0.96%
317,623 Common Stock
Mar 31 2022
BUY
Exercise of conversion of derivative security
$68,157 $1.89 p/Share
36,062 Added 10.59%
304,442 Common Stock
Dec 14 2021
BUY
Open market or private purchase
$46,400 $11.6 p/Share
4,000 Added 1.47%
268,380 Common Stock
Dec 13 2021
BUY
Open market or private purchase
$48,480 $12.12 p/Share
4,000 Added 1.49%
264,380 Common Stock
AC

Andrew Combs

Chief Chemistry Officer
Wilmington, DE

Track Institutional and Insider Activities on PRLD

Follow Prelude Therapeutics Inc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PRLD shares.

Notify only if
Any

Insider Trading

Get notified when an Prelude Therapeutics Inc insider buys or sells PRLD shares.

Notify only if
Any
Any
P - Open market or private purchase×
S - Open market or private sale×
V - Transaction voluntarily reported earlier than required×
A - Grant, award, or other acquisition×
D - Sale (or disposition) back to the issuer×
F - Payment of exercise price or tax liability×
I - Discretionary transaction×
M - Exercise of conversion of derivative security×
C - Conversion of derivative security×
E - Expiration of short derivative position×
H - Expiration (or cancellation) of long derivative position with value received×
O - Exercise of out-of-the-money derivative securities×
X - Exercise of in-the-money or at-the-money derivatives securities×
G - Bona fide gift×
L - Small Acquisition×
W - Acquisition or disposition by will or laws×
Z - Deposit into or withdrawal from voting trust×
J - Other acquisition or disposition×
K - Transaction in equity swap or similar instrument×
U - Disposition due to a tender of shares in a change of control transaction×
20 item(s) selected

News

Receive news related to Prelude Therapeutics Inc

Track Activities on PRLD